3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Vomiting
11
Nausea
5
Neoplasms
2
Breast Neoplasms
2
Solid Tumors
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Breast Neoplasms, Male
1
Interventions
pertuzumab
1
iniparib
1
Trastuzumab
1
Topotecan
1
Palonosetron
1
Paclitaxel
1
Metoclopramide
1
Irinotecan
1
Gemcitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Solid Tumors
×
Palonosetron
×
Clear all
NCT02135510
2020-03-31
MEDEA
Amsterdam UMC, location VUmc
Phase 3
Completed
249 enrolled